NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-259-1988-0-US-01 Esters of 3-Demethylthiocolchicine and N-Acyl Analogs as Substitutes of Colchicine in Diseases Treated With ... US ORD 07/235,907 Abandoned
NIA E-313-1987-0-DK-12 Enhancing Drug Delivery to the Brain DK EP 88307767.9 Abandoned
NIA E-313-1987-0-EP-07 Ramified alkyl esters of 4-bis(chloroethyl)aminophenyl-alkyl carboxylic acids EP National Stage 88307767.9 Abandoned
NHLBI E-294-1988-0-US-01 CD4 Expression Vehicle and Use Thereof US ORD 07/234,646 Abandoned
NIAID E-205-1988-0-US-01 SYNTHETIC, ANTI-COMPLEMENT PROTEIN AND THE GENE ENCODING SAME US ORD 07/239,208 5157110 Expired PDF
NIAID E-170-1988-0-US-01 Recombinant Vaccinia Virus for Prevention of Disease Caused by Flavivirus US ORD 07/239,205 Abandoned
NIA E-313-1987-0-JP-06 Enhancing Drug Delivery to the Brain JP National Stage 507717/88 Abandoned
NIA E-313-1987-0-CA-05 Enhancing Drug Delivery to the Brain CA National Stage 575223 Abandoned
NIA E-313-1987-0-PT-18 Enhancing Drug Delivery to the Brain PT EP 88309 Abandoned
NIA E-313-1987-0-CH-10 Enhancing Drug Delivery to the Brain CH EP 88307767.9 Abandoned
NIA E-313-1987-0-ES-21 Enhancing Drug Delivery to the Brain ES EP 88307767.9 Abandoned
NIA E-313-1987-0-SE-19 Enhancing Drug Delivery to the Brain SE EP 88307767.9 Abandoned
NIA E-313-1987-0-AT-08 Enhancing Drug Delivery to the Brain AT EP 88307767.9 Abandoned
NIA E-313-1987-0-BE-09 Enhancing Drug Delivery to the Brain BE EP 88307767.9 Abandoned
NIA E-313-1987-0-DE-11 Enhancing Drug Delivery to the Brain DE EP 88307767.9 Abandoned
NIA E-313-1987-0-GR-14 Enhancing Drug Delivery to the Brain GR EP 3005338 Abandoned
NIA E-313-1987-0-FR-13 Enhancing Drug Delivery to the Brain FR EP 88307767.9 Abandoned
NIA E-313-1987-0-IE-15 Enhancing Drug Delivery to the Brain IE EP 88307767.9 Abandoned
NIA E-313-1987-0-IT-16 Enhancing Drug Delivery to the Brain IT EP 88307767.9 Abandoned
NIA E-313-1987-0-GB-03 Enhancing Drug Delivery to the Brain GB EP 88307767.9 Abandoned
NIA E-313-1987-0-NL-20 Enhancing Drug Delivery to the Brain NL EP 88307767.9 Abandoned
NIA E-313-1987-0-LU-17 Enhancing Drug Delivery to the Brain LU EP 88307767.9 Abandoned
NIA E-313-1987-0-AU-04 Enhancing Drug Delivery to the Brain AU National Stage 24271/88 Abandoned
CC E-203-1988-0-US-01 In-vivo method for determining and imaging temperature of an object/ subject from diffusion coefficients obtained US ORD 07/234,101 4914608 Expired PDF
NIA E-313-1987-0-PCT-02 Enhancing Drug Delivery to the Brain PCT PCT PCT/US88/002836 Expired
NCI E-249-1988-0-US-01 MONOCLONAL ANTIBODY (D612) HAVING SELECTIVE REACTIVITY FOR GASTROINTESTINAL CARCINOMAS AND METHODS FOR EMPLOYING SAME. US ORD 07/234,130 Abandoned
NCI E-306-1987-0-CA-03 METHOD FOR TREATING MALIGNANCY AND AUTOIMMUNE DISORDERS IN HUMANS CA National Stage 574976 Expired
NCI E-306-1987-0-JP-04 METHOD FOR TREATING MALIGNANCY AND AUTOIMMUNE DISORDERS IN HUMANS JP National Stage 507708/88 Expired
NCI E-306-1987-0-EP-05 METHOD FOR TREATING MALIGNANCY AND AUTOIMMUNE DISORDERS IN HUMANS EP National Stage 88908490.1 Abandoned
NCI E-306-1987-0-PCT-02 No_Patent_Title PCT PCT PCT/US88/002731 Expired
NCI E-605-1987-0-US-01 CLONE-PRODUCED CELL LINE FOR PRODUCTION OF HTLV-I US ORD 07/230,817 Abandoned
NIEHS E-495-1987-1-US-01 NEW PLASMID SYSTEM US CIP 07/230,571 Abandoned
NCI E-454-1986-2-US-01 Human B Lymphotropic Virus US CIP 07/228,550 Abandoned
NIDDK E-597-1987-0-US-01 CARBOHYDRATE RECEPTOR FOR BACTERIA AND METHOD FOR USE THEREOF US ORD 07/226,445 5217715 Expired PDF
NCI E-154-1976-0-US-01 Circle Array Tomography System US ORD 07/226,334 Abandoned
NIAID E-220-1988-0-US-01 CD-4/CYTOTOXIC GENE FUSIONS US ORD 07/223,270 5206353 Expired PDF
NIMH E-245-1988-0-US-01 APPARATUS AND METHOD FOR TRANSMITTING PROSTHETIC INFORMATION TO THE BRAIN US ORD 07/222,882 5037376 Expired PDF
NCI E-222-1988-0-US-01 SYNTHETIC VACCINE AGAINST AIDS VIRUS US ORD 07/222,684 5030449 Expired PDF
NIDCR E-521-1986-1-US-02 Peptides with Laminin Activity US DIV 07/221,982 Abandoned
NCI E-529-1986-0-US-02 ANTINEOPLASTIC, SYSTEM-L-SPECIFIC AMINO ACID NITROGEN MUSTARDS US DIV 07/221,613 Abandoned
NIDDK E-201-1988-0-US-01 IRREVERSIBLE INHIBITORS OF ADENOSINE RECEPTORS US ORD 07/221,413 Abandoned
NIAID E-171-1988-0-US-01 Vaccine for Dengue Virus US ORD 07/218,852 Abandoned
NCI E-160-1987-0-CA-04 SECOND GENERATION MONOCLONAL ANTIBODIES HAVING BINDING SPECIFICITY TO TAG-72 AND HUMAN CARCINOMAS AND ....... CA National Stage 571894 Expired
NCI E-183-1988-0-US-01 Synthetic HIV Protease Gene and Method for Its Expression US CIP 07/218,304 Abandoned
NCI E-102-1988-0-US-01 Cell Lines for Overexpressing the Human PDGF-A Gene Product and Method Therefor US ORD 07/218,276 Abandoned
NIAID E-007-1981-3-US-01 Vaccine Against Hepatitis A Virus US CIP 07/217,824 4894228 Expired PDF
NCI E-317-1984-16-US-02 Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells US CON 07/221,303 Abandoned
NIAID E-226-1988-0-US-01 Synthetic Vaccine Against P. Falciparum Malaria US ORD 07/216,088 5028425 Expired PDF
NCI E-272-1988-0-US-01 METHOD OF TREATING DISEASES CAUSED BY IMMUNODEFICIENCY STATES BY ADMINISTERING HNCF TO HUMANS US ORD 07/216,418 Abandoned
NCI E-521-1985-0-NZ-10 Plasmid and Phage Clones of Human T-Cell Lymphotropic Virus Type III NZ DIV 225300 Abandoned